Next spring, Carl Zeiss will begin shipping its Lightsheet Z.1 Light Sheet Microscope System, which was introduced this month at the Society for Neuroscience Annual Meeting. The original light sheet microscopy technology the System is based on was introduced by Carl Zeiss in the 1900s and has been adapted for three-dimensional fluorescence imaging in biology. […]

Company Announcements Wako Pure Chemical Industries agreed in May to market and service Yokogawa Electric’s CellVoyager CV7000 high-throughput cytological discovery system in North America and Europe. Yokogawa combines the system with a high-throughput screening system, providing a total drug discovery automation solution. In June, Fluxion Biosciences announced collaboration with the Stanford University School of Medicine. […]

Company Announcements The International Board of Biosafety Associations announced in April collaboration with Nuaire to improve the functionality of biological safety cabinets in Southeast Asia, Africa and other regions. JG Finneran Associates appointed Chebios in June as its exclusive distributor for Italy. Porvair reported that Seal Analytical sales for the half year ending May 31 […]

Company Announcements Quanterix named Paul Chapman president and CEO in July. Previously, he was vice president of the BioPharma Process Solutions at EMD Millipore. Pacific Biosciences named David Botstein, PhD, to its Board in July. He is director of the Lewis-Sigler Institute for Integrative Genomics and Anthony B. Evnin Professor of Genomics at Princeton University. […]

Company Announcements NorDiag sold its molecular diagnostics assets in May to DiaSorin for €7.6 million ($10.0 million) and changed its name to Norda. It will continue to sell its Magnatrix automated DNA purification systems. Precision System Science reorganized its structure, effective July 1, setting up a Global Sales & Marketing Group, Production and Supply Management […]

Australia’s midyear budget will cut Sustainable Research Excellence (SRE) grants by 40% to AUD 79 million ($81.9 million) for 2012–2013. Although research grants were not subject to cuts, the SRE grants, which have supported overhead expenses for research since 2009, will receive AUD 499 million less over the next four years than originally announced. Funding […]

R&D spending in China continued to grow in 2011, increasing 23% to CNY 868.7 billion ($139 billion). R&D spending accounted for 1.84% of the country’s GDP, up from 1.76% in 2010. Investment in basic research, applied research and experimental development, a term the Chinese government defines as “systematic activities aiming at using the knowledge from […]

The Turkish Association of Research-Based Pharmaceutical Companies’ (AFID) “Vision 2023” report released earlier this month recommends ways to make the country among the top 10 countries in health services by 2023. Turkey’s pharmaceutical market was valued at $11.2 billion in 2011, ranking 16th in the world. However, in 2011, Turkey’s 70 clinical trials supported by […]

Since 2009, six prominent US sterile-injectable drug makers have received FDA warnings regarding manufacturing procedures. As a result, the manufacturing capacity for injectables has been reduced by almost one-third, according to a congressional report. Four of the firms shut down or decreased production to address the issues. Compounding pharmacies have attempted to provide the products, […]